As SEC Guidance Brings New Deals to Near Halt, New Forum Helps SPACs Find Affordable and Optimal Target Acquisitions

SAN DIEGO — (BUSINESS WIRE) — In a move to enable SPACs (Special Interest Acquisition Companies), Manhattan Street Capital, Inc. (www.manhattanstreetcapital.com) has launched the SPAC Finder MatchMaker Forum, making it easy for funded SPACs to find attractive targets to acquire and for acquisition prospects to identify and approach suitable funded SPACs.

“In short, we’re enabling the backlog of Funded, post IPO SPACS to reach their fullest potential during a newly challenging context, before their two-year investor refund deadline hits”

This efficiency…


The Arcimoto Reg A+ IPO to the NASDAQ has now listed and is trading with the ticker symbol NASDAQ:FUV (which stands for “Fun Utility Vehicle”). Arcimoto is the fifth Reg A+ IPO, to complete and list on a major exchange in the last four months (and the fourth to list on the NASDAQ). Here we explore the unique aspects of the Arcimoto capital raise.

Arcimoto is the second pure EV company to go public, the first being Tesla. The stock initiates at $6.50 per share , the offering has raised approximately $19 million. …


Wednesday, April 7th, 09:00 am — 10:10 am (PDT) | 12:00 pm to 03:10 pm (EST)

Sign up for the webinar for free, it only takes 10 seconds

Sign Up For The Webinar

If you sign up for the webinar we will send you the webinar recording later, so we suggest that you sign up even if you can’t attend the webinar.

Rod Turner will describe the Manhattan Street Fund — Learn About This Investment Opportunity.

Agenda items for the webinar:

- Review the market environment

- Discuss the Fund strategy

- Types of companies that we will focus on


What is Rule 144A and how can I use it to raise capital and list my company?

Rule 144A is a capital-raising method that can be offered and marketed online to Institutional investors in the US and any investor outside the US via Reg S. It is simple and offers the Issuing company the ability to publicly list its security post offering for public trading by US Institutional investors.

Up-front disclosures are minimal, SEC filing is simple and rapid, and Institutions are immediately liquid. …


Thursday, April 1st, 11:00 am — 12:20 pm (PDT) | 2:00 pm to 3:20 pm (EST)

Sign up for the webinar for free, it only takes 10 seconds

Sign Up For The Webinar

If you sign up for the webinar we will send you the webinar recording later, so we suggest that you sign up even if you can’t attend the webinar.

In this webinar, we will be discussing How To Choose The Optimum Valuation For Your Reg A+ Capital Raise

Agenda items for the webinar:

- Resources

- Valuation Professionals

- Choice of methods

- When you can change…


Thursday, March 11th, 11:00 am — 12:15 pm (PST) | 2:00 pm to 3:15 pm (EST)

Sign up for the webinar for free, it only takes 10 seconds

Sign Up For The Webinar

In this webinar, we will be discussing the Differences Between Reg A+, Reg D & Rule 144A

- Key differences between Reg D 506b, 506c, Reg A+ and Rule 144A
- Examples where each one works well
- The methods that must be used
- Marketing methods and costs
- Liquidity options for each

Questions and Answers — You are welcome to send us your questions ahead…


According to the Securities Act of 1933, every company has to register its offering with the SEC in order to sell its shares. There are situations where exemptions allow the companies to sell their shares without an SEC registration. There are two exemptions — Reg D 506b and Reg D 506c.

Reg D 506b and Reg D 506c

Reg D provides three exemptions from the registration, Rule 504, Rule 505 and Rule 506. For purposes of online equity crowd investing, Rule 506 is most significant, and it splits into two different variations, 506b, and 506c. In each case, only accredited…


Identify Sensors Biologics

A highly accurate, portable, and reusable COVID self-test for smartphones

Purdue University and IdentifySensors Biologics have partnered to create Check4-COVID™: a highly accurate, over-the-counter device intended to detect COVID-19 RNA in minutes in early and asymptomatic infections.

The device uses newly developed nanosensors, saliva, and a smartphone to pinpoint infections in minutes that current tests and home tests miss. It is intended to be sold at pharmacies at $80 for the device and $21 for each test. The system will also detect the new variants of COVID-19. This over-the-counter device is intended to be used entirely at…

Rod Turner

Serial entrepreneur, leader, expert in mergers, scaling up businesses, Reg A+ & IPOs. Optimal health. CEO ManhattanStreetCapital.com

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store